Bispecific Antibodies Versus Chimeric Antigen Receptor T‐Cell Therapy in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma: A Comparative Narrative Review of Efficacy, Safety, and Accessibility
This review provides clinicians with a comprehensive comparison to support evidence-based treatment selection in rel/ref DLBCL.
Authors
- Mable Pereira
- Fayza Akil
- Samia Zuhair Sabbagh
- Fatma ElSayed Hassan
- Dana Sofian Abou
- Husna Irfan Thalib
- Hala Sofian Abou
Institutions
- Texila American University (GY)
- University of Jeddah (SA)
- University of Business and Technology (SA)
- Batterjee Medical College
Publication Details
- Journal
- Cancer Medicine
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1002/cam4.71562
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00